Skip to content

Clinical trials

Irritable Bowel Syndrome trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Irritable Bowel Syndrome Country / region: Italy Clear all

63 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20041
20061
20071
20081
20102
20111
20123
20132
20142
20154
20164
20172
20184
20192
20201
20217
20225
20234
20245
20256
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed39
Recruiting10
Unknown status9
Not yet recruiting2
Terminated2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Bari7
University of Palermo7
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis6
Fondazione Policlinico Universitario Agostino Gemelli IRCCS5
SOFAR S.p.A.5
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico3
Istituto Clinico Humanitas3
Azienda di Servizi alla Persona di Pavia2
Federico II University2
Menarini Group2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Irritable Bowel Syndrome63
Celiac Disease10
Abdominal Pain7
Inflammatory Bowel Diseases4
Diarrhea3
Dysbiosis3
Colitis, Ulcerative2
Constipation2
Fibromyalgia2
Gastrointestinal Diseases2

Trials

Showing 76 to 63 of 63. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.